Benchmark gauges notched all-time highs as stocks charged through a busy earnings season.
Source
January was great for stocks — here are our top 5 performers for the month
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021. Andrew Kelly | Reuters Merck on Thursday said its experimental treatment designed to protect infants from respiratory syncytial virus showed positive results in a mid- to late-stage trial, bringing the company one step closer to filing […]
Read MoreTeen tobacco use falls to 25-year low as fewer pick up e-cigarettes
In this photo illustration, ZYN nicotine cases and pouches are seen on a table on January 29, 2024 in New York City. Michael M. Santiago | Getty Images Tobacco product use among middle and high school students has dropped to a 25-year low, the Centers for Disease Control and Prevention and the U.S. Food and […]
Read MoreEmbattled Abbott Labs comes through with a strong quarter, buyback announcement
Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and upped its earnings guidance for the third straight quarter. Shares rose more than 1%, shaking off an initially subdued reaction. Revenue in the three months ended Sept. 30 rose 4.9% to $10.64 billion, topping estimates of $10.55 billion, according to data provider LSEG. […]
Read More